Changes 1_2010 1_2011 1_2012 1_2013 1_2014 1_2015 related to LT: change in methodology BE: increase in % for price BE: link no longer constantly - BE: increase in % for pr. - pricing of of G pr. link difference between O and G, applied difference between O and G generics (G) extra % after 2 and 4 yrs. CZ: change in % P + R 2_2013 FR: reduction in G prices 2_2015 (e.g., G 2_2010 LV: change in methodology decrease in case of market EL: price link for G (med. NO: lower G pr. following pr. - price link) - of G price link higher % entry of 1st G or biosimilar with MA after 01/01/2012) to comparison to DK and SE – between O and G med. prices of corresponding PT: new rules for the pr. of G SI: new pricing rule for G FR: change in of G pr. link med. (lower G prices) LV: change in methodology IE: G with pr. of 50% of 2_2014 of G pr. link reference O after 1 yr. EL: change in G pr. policy 2_2011 PT: change in methodology TR: decrease in R price for SE: change in pr. ceiling for of G pr. link G specific on-patent med. with RS: change in methodology generic competition of G price link TR: change in % of G price SI: lowering maximum link allowed pr. for G 2_2012 BG: introduction of G pr. link IE: G with pr. of 60% of reference O LT: legal basis for G pr. reduction NO: pr. comparison of G to DK and SE PT: change in methodology of G pr. link O pr.)
Changes related to pricing of generics (G) (e.g., G price link) 1_2010 LT: change in methodology of G pr. link 2_2010 - 1_2011 BE: increase in % for price difference between O and G, extra % after 2 and 4 yrs. LV: change in methodology of G price link – higher % between O and G SI: new pricing rule for G (lower G prices) 2_2011 SE: change in pr. ceiling for specific on-patent med. with generic competition TR: change in % of G price link 1_2012 BE: link no longer constantly applied CZ: change in % P + R decrease in case of market entry of 1st G or biosimilar med. FR: change in of G pr. link LV: change in methodology of G pr. link PT: change in methodology of G pr. link RS: change in methodology of G price link SI: lowering maximum allowed pr. for G 2_2012 BG: introduction of G pr. link IE: G with pr. of 60% of reference O LT: legal basis for G pr. reduction NO: pr. comparison of G to DK and SE PT: change in methodology of G pr. link O pr.) 1_2013 - 2_2013 EL: price link for G (med. with MA after 01/01/2012) to prices of corresponding med. IE: G with pr. of 50% of reference O after 1 yr. 1_2014 BE: increase in % for pr. difference between O and G FR: reduction in G prices NO: lower G pr. following pr. comparison to DK and SE PT: new rules for the pr. of G 2_2014 EL: change in G pr. policy TR: decrease in R price for G 1_2015 - 2_2015 -
1-s2.0-S0168851016302366-mmc3.docx